Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q1

4078.TEDINET S100OUSM
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥21.4bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥19.6bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.8bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥2.1bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥2.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥2.6bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥127.2bnat 2022-06-30Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥123.6bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥43.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥84.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥80.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥12.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥109.42022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.222021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥558m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-06-30¥19.8bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-06-30¥19.5bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥360m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.3bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥74m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-06-30¥89m
—segment totalrevenue2022-04-01 → 2022-06-30¥21.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥21.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥435m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥449m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥449m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥521m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-06-30¥17.7bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥385m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥63m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-06-30¥27m
—segment totalrevenue2021-04-01 → 2021-06-30¥20.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥19.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥449m
—segment totalsegment profit2021-04-01 → 2021-06-30¥2.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 363
ItemContextValueUnit
Valuation and translation adjustmentsPrior1YearInstant1081000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant1089000000JPY
Non controlling interestsPrior1YearInstant3854000000JPY
Non controlling interestsCurrentQuarterInstant3963000000JPY
Net assetsPrior1YearInstant82708000000JPY
Net assetsCurrentQuarterInstant84028000000JPY
Liabilities and net assetsPrior1YearInstant123919000000JPY
Liabilities and net assetsCurrentQuarterInstant127230000000JPY
Net salesPrior1YTDDuration19577000000JPY
Net salesCurrentYTDDuration21400000000JPY
Cost of salesPrior1YTDDuration14057000000JPY
Cost of salesCurrentYTDDuration16010000000JPY
Gross profitPrior1YTDDuration5519000000JPY
Gross profitCurrentYTDDuration5390000000JPY
Selling general and administrative expensesPrior1YTDDuration3380000000JPY
Selling general and administrative expensesCurrentYTDDuration3563000000JPY
Operating incomePrior1YTDDuration2138000000JPY
Operating incomeCurrentYTDDuration1826000000JPY
Interest income noiPrior1YTDDuration2000000JPY
Interest income noiCurrentYTDDuration1000000JPY
Dividends income noiPrior1YTDDuration130000000JPY
Dividends income noiCurrentYTDDuration86000000JPY
Foreign exchange gains noiPrior1YTDDuration99000000JPY
Foreign exchange gains noiCurrentYTDDuration221000000JPY
Other noiPrior1YTDDuration22000000JPY
Other noiCurrentYTDDuration25000000JPY
Non operating incomePrior1YTDDuration255000000JPY
Non operating incomeCurrentYTDDuration333000000JPY
Interest expenses noePrior1YTDDuration18000000JPY
Interest expenses noeCurrentYTDDuration17000000JPY
Other noePrior1YTDDuration15000000JPY
Other noeCurrentYTDDuration18000000JPY
Non operating expensesPrior1YTDDuration34000000JPY
Non operating expensesCurrentYTDDuration35000000JPY
Ordinary incomePrior1YTDDuration2359000000JPY
Ordinary incomeCurrentYTDDuration2125000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration90000000JPY
Gain on sales of investment securities eiCurrentYTDDuration70000000JPY
Gain on sales of golf memberships eiPrior1YTDDuration－JPY
Gain on sales of golf memberships eiCurrentYTDDuration1000000JPY
Insurance income eiPrior1YTDDuration－JPY
Insurance income eiCurrentYTDDuration380000000JPY
Extraordinary incomePrior1YTDDuration90000000JPY
Extraordinary incomeCurrentYTDDuration453000000JPY
Loss on explosion and fire accident elPrior1YTDDuration53000000JPY
Loss on explosion and fire accident elCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration8000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration5000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass